Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they ...

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...

The sell-off started last night and continued in after-hours trading after the New York-based biopharma company revealed that ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Great Place to Work, Built Ins: Top Biotech Companies 2024, Forbes Best Places to Work in Life Sciences are joining our LEAP ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...